Optometrist Education Evening
Date: 19/07/2023 (AEST)
Venue: 4 Makin Place, Deakin, ACT, 2600
Provider: CANBERRA EYE SURGEONS
Contact: Carly Morton, [E] office@canberraeye.com.au, [P] 02 6249 6000
Learning Objectives
- Identify new therapies available for the treatment of neovascular (wet) age-related macular degeneration (AMD) and their potential advantages
- Recognise potential new treatments for the management of atrophic (dry) AMD and the role they may play in ongoing patient care
- Discuss recent developments in models of patient care and possible future therapies under investigation for both wet and dry AMD
- Understand the rationale for treatment of normal tension glaucoma
- Understand the potential adverse drug reactions of commonly used topical glaucoma medications
- Understand and be able to escalate the care of patients with progressive glaucomatous optic neuropathy
- Gain insight into the co-management of glaucoma between Optometrist and Ophthalmologist
- Recognise emergencies and referral pathways in patients with glaucoma
- Recognise that glaucoma may be secondary to other ophthalmic and systemic conditions
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| What's New in Age-Related Macular Degeneration |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Glaucoma: Stuff you wanted to know but were afraid to ask |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |